- This Week at FDA: FDA Official Criticizes UniQure, States Eye Cheaper Drug Imports, and More
- This Week at FDA: Speedy Drug Review Bonuses, Makary Defends Prasad, and More
- FDA Publishes New Product-Specific Guidances to Facilitate Generic Drug Development
- This Week at FDA: Single Pivotal Trials, FDA Reverses Course to Review Moderna Flu Vaccine, and Makary’s OTC Turn
- This Week at FDA: QMSR and PreCheck Kickoff, Makary Tries to Ease CNPV Concerns, and More
